KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $345.2 million.

  • Edwards Lifesciences' Cost of Revenue rose 3130.47% to $345.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 1924.18%. This contributed to the annual value of $1.1 billion for FY2024, which is 1421.71% up from last year.
  • Per Edwards Lifesciences' latest filing, its Cost of Revenue stood at $345.2 million for Q3 2025, which was up 3130.47% from $344.4 million recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Cost of Revenue high stood at $345.2 million for Q3 2025, and its period low was -$98.8 million during Q4 2022.
  • Over the past 5 years, Edwards Lifesciences' median Cost of Revenue value was $292.2 million (recorded in 2024), while the average stood at $272.1 million.
  • As far as peak fluctuations go, Edwards Lifesciences' Cost of Revenue tumbled by 13192.25% in 2022, and later surged by 35404.86% in 2023.
  • Over the past 5 years, Edwards Lifesciences' Cost of Revenue (Quarter) stood at $309.5 million in 2021, then crashed by 131.92% to -$98.8 million in 2022, then skyrocketed by 354.05% to $251.0 million in 2023, then grew by 16.41% to $292.2 million in 2024, then grew by 18.14% to $345.2 million in 2025.
  • Its Cost of Revenue stands at $345.2 million for Q3 2025, versus $344.4 million for Q2 2025 and $301.6 million for Q1 2025.